BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34736627)

  • 1. Neurogenic arthrogryposis and the power of phenotyping.
    Rossor AM; Reilly MM
    Neuromuscul Disord; 2021 Oct; 31(10):1062-1069. PubMed ID: 34736627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMALED2 with BICD2 gene mutations: Report of two cases and portrayal of a classical phenotype.
    Picher-Martel V; Morin C; Brunet D; Dionne A
    Neuromuscul Disord; 2020 Aug; 30(8):669-673. PubMed ID: 32709491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic extremes of BICD2-opathies: from lethal, congenital muscular atrophy with arthrogryposis to asymptomatic with subclinical features.
    Storbeck M; Horsberg Eriksen B; Unger A; Hölker I; Aukrust I; Martínez-Carrera LA; Linke WA; Ferbert A; Heller R; Vorgerd M; Houge G; Wirth B
    Eur J Hum Genet; 2017 Sep; 25(9):1040-1048. PubMed ID: 28635954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy.
    Rossor AM; Sleigh JN; Groves M; Muntoni F; Reilly MM; Hoogenraad CC; Schiavo G
    Acta Neuropathol Commun; 2020 Mar; 8(1):34. PubMed ID: 32183910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.
    Rossor AM; Oates EC; Salter HK; Liu Y; Murphy SM; Schule R; Gonzalez MA; Scoto M; Phadke R; Sewry CA; Houlden H; Jordanova A; Tournev I; Chamova T; Litvinenko I; Zuchner S; Herrmann DN; Blake J; Sowden JE; Acsadi G; Rodriguez ML; Menezes MP; Clarke NF; Auer Grumbach M; Bullock SL; Muntoni F; Reilly MM; North KN
    Brain; 2015 Feb; 138(Pt 2):293-310. PubMed ID: 25497877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-frame de novo mutation in
    Koboldt DC; Kastury RD; Waldrop MA; Kelly BJ; Mosher TM; McLaughlin H; Corsmeier D; Slaughter JL; Flanigan KM; McBride KL; Mehta L; Wilson RK; White P
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30054298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into SMALED2: BICD2 mutations increase microtubule stability and cause defects in axonal and NMJ development.
    Martinez Carrera LA; Gabriel E; Donohoe CD; Hölker I; Mariappan A; Storbeck M; Uhlirova M; Gopalakrishnan J; Wirth B
    Hum Mol Genet; 2018 May; 27(10):1772-1784. PubMed ID: 29528393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal dominant spinal muscular atrophy with lower extremity predominance: A recognizable phenotype of BICD2 mutations.
    Rudnik-Schöneborn S; Deden F; Eggermann K; Eggermann T; Wieczorek D; Sellhaus B; Yamoah A; Goswami A; Claeys KG; Weis J; Zerres K
    Muscle Nerve; 2016 Sep; 54(3):496-500. PubMed ID: 26998597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genotypic and Phenotypic Spectrum of BICD2 Variants in Spinal Muscular Atrophy.
    Koboldt DC; Waldrop MA; Wilson RK; Flanigan KM
    Ann Neurol; 2020 Apr; 87(4):487-496. PubMed ID: 32057122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of severe autosomal dominant spinal muscular atrophy with lower extremity predominance caused by a de novo BICD2 mutation.
    Ueda Y; Suganuma T; Narumi-Kishimoto Y; Kaname T; Sato T
    Brain Dev; 2021 Jan; 43(1):135-139. PubMed ID: 32888736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal early motor neuron disruption and prenatal molecular diagnosis in a severe BICD2-opathy.
    Marchionni E; Agolini E; Mastromoro G; Guadagnolo D; Coppola G; Roggini M; Riminucci M; Novelli A; Giancotti A; Corsi A; Pizzuti A
    Am J Med Genet A; 2021 May; 185(5):1509-1514. PubMed ID: 33547725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset SMALED2 due to a novel
    Wan C; Wang Y; Zhou Q; Yu Y; Hong D; Zhu M
    Clin Neuropathol; 2019; 38(3):109-117. PubMed ID: 30738493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-frame deletion in BICD2 associated with a non-progressive form of SMALED.
    Trimouille A; Obre É; Banneau G; Durr A; Stevanin G; Clot F; Pennamen P; Perez JT; Bailly-Scappaticci C; Rouanet M; Delleci C; Sole G; Mathis S; Goizet C
    Clin Neurol Neurosurg; 2018 Mar; 166():1-3. PubMed ID: 29353221
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term follow-up of a patient with autosomal dominant lower extremity-predominant spinal muscular atrophy-2 due to a BICD2 variant.
    Yamamoto K; Ohashi K; Fujimoto M; Ieda D; Nakamura Y; Hattori A; Kaname T; Ieda K; Nishino I; Saitoh S
    Brain Dev; 2022 Sep; 44(8):578-582. PubMed ID: 35527075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of FOUR iPSC lines (CRICKi004-A; CRICKi005-A; CRICKi006-A, CRICKi007-A) from Spinal muscle atrophy patients with lower extremity dominant (SMALED) phenotype.
    Devito LG; Cooper F; D'Angelo I; Smith J; Healy L
    Stem Cell Res; 2022 Dec; 65():102954. PubMed ID: 36332468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel BICD2 mutation in a Japanese family with autosomal dominant lower extremity-predominant spinal muscular atrophy-2.
    Yoshioka M; Morisada N; Toyoshima D; Yoshimura H; Nishio H; Iijima K; Takeshima Y; Uehara T; Kosaki K
    Brain Dev; 2018 Apr; 40(4):343-347. PubMed ID: 29273277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent de novo BICD2 mutation associated with arthrogryposis multiplex congenita and bilateral perisylvian polymicrogyria.
    Ravenscroft G; Di Donato N; Hahn G; Davis MR; Craven PD; Poke G; Neas KR; Neuhann TM; Dobyns WB; Laing NG
    Neuromuscul Disord; 2016 Nov; 26(11):744-748. PubMed ID: 27751653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival motor neuron gene deletion in the arthrogryposis multiplex congenita-spinal muscular atrophy association.
    Bürglen L; Amiel J; Viollet L; Lefebvre S; Burlet P; Clermont O; Raclin V; Landrieu P; Verloes A; Munnich A; Melki J
    J Clin Invest; 1996 Sep; 98(5):1130-2. PubMed ID: 8787675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital segmental spinal muscular atrophy: a case report.
    Savaş T; Erol I; Özkale Y; Saygi S
    J Child Neurol; 2015 Mar; 30(4):509-12. PubMed ID: 25300987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.
    Oates EC; Rossor AM; Hafezparast M; Gonzalez M; Speziani F; MacArthur DG; Lek M; Cottenie E; Scoto M; Foley AR; Hurles M; Houlden H; Greensmith L; Auer-Grumbach M; Pieber TR; Strom TM; Schule R; Herrmann DN; Sowden JE; Acsadi G; Menezes MP; Clarke NF; Züchner S; ; Muntoni F; North KN; Reilly MM
    Am J Hum Genet; 2013 Jun; 92(6):965-73. PubMed ID: 23664120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.